Proteomic profiling implies mitochondrial dysfunction in tachycardia-induced heart failure

Journal of Cardiac Failure

Volumn 18, Issue 8, 2012, Pages 660-673

  Birner, Christoph ^a   Dietl, Alexander ^a   Deutzmann, Rainer ^a   Schröder, Josef ^b   Schmid, Peter ^a   Jungbauer, Carsten ^a   Resch, Markus ^a   Endemann, Dierk ^a   Stark, Klaus ^a   Riegger, Günter ^a   Luchner, Andreas ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

energetics; Heart failure; proteomics

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; NITRIC OXIDE; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; GENE EXPRESSION; HEART LEFT VENTRICLE FAILURE; HEART PACING; HEART RIGHT VENTRICLE FAILURE; HYPOTENSION; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; RABBIT; RESPIRATORY CHAIN; STRESS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANALYSIS OF VARIANCE; ANIMALS; CARDIAC PACING, ARTIFICIAL; GENE EXPRESSION PROFILING; HEART FAILURE; MALE; MITOCHONDRIA; MITOCHONDRIAL DISEASES; MYOCARDIUM; NITRIC OXIDE; PROTEOMICS; RABBITS; TACHYCARDIA; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84864440403     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2012.06.418     Document Type: Article

References (44)

1. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, R.J. Adams, J.D. Berry, and T.M. Brown Heart disease and stroke statistics-2011 update: a report from the American Heart Association Circulation 123 2011 e18 e209
2. K. Dickstein, A. Cohen-Solal, G. Filippatos, J.J.V. McMurray, P. Ponikowski, and P.A. Poole-Wilson ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail 10 2008 933 989
3. D.L. Brutsaert Cardiac failure: quo vadis? Eur J Heart Fail 12 2010 785 788
4. M. Ouzounian, D.S. Lee, A.O. Gramolini, A. Emili, M. Fukuoka, and P.P. Liu Predict, prevent and personalize: genomic and proteomic approaches to cardiovascular medicine Can J Cardiol 23 2007 28A 33A
5. J. Siwy, A. Vlahou, L.U. Zimmerli, P. Zürbig, and E. Schiffer Clinical proteomics: current techniques and potential applications in the elderly Maturitas 68 2011 233 244
6. E. McGregor, and M.J. Dunn Proteomics of heart disease Hum Mol Genet 12 2003 R135 R144
7. M.J. Dunn Studying heart disease using the proteomic approach Drug Discov Today 5 2000 76 84
8. N. Bousette, A.O. Gramolini, and T. Kislinger Proteomics-based investigations of animal models of disease Proteomics Clin Appl 2 2008 638 653
9. G.W. Moe, and P. Armstrong Pacing-induced heart failure: a model to study the mechanism of disease progression and novel therapy in heart failure Cardiovasc Res 42 1999 591 599
10. D. Elsner, and G.A. Riegger Characteristics and clinical relevance of animal models of heart failure Curr Opin Cardiol 10 1995 253 259
11. A. Luchner, F. Muders, O. Dietl, E. Friedrich, F. Blumberg, and A.A. Protter Differential expression of cardiac ANP and BNP in a rabbit model of progressive left ventricular dysfunction Cardiovasc Res 51 2001 601 607
12. T.L. Stevens, D.D. Borgeson, A. Luchner, P.W. Wennberg, and M. Redfield A modified model of tachycardia-induced cardiomyopathy: insights into humoral and renal adaptations F. Spinale, Tachycardia-induced Cardiomyopathy 1996 Futura Press
13. A. Luchner, T.L. Stevens, D.D. Borgeson, M.M. Redfield, J.E. Bailey, and S.M. Sandberg Angiotensin II in the evolution of experimental heart failure Hypertension 28 1996 472 477
14. A. Luchner, T.L. Stevens, D.D. Borgeson, M. Redfield, C.M. Wei, and J.G. Porter Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure Am J Physiol 274 1998 H1684 H1689
15. A. Luchner, M. Jougasaki, E. Friedrich, D.D. Borgeson, T.L. Stevens, and M.M. Redfield Activation of cardiorenal and pulmonary tissue endothelin-1 in experimental heart failure Am J Physiol Regul Integr Comp Physiol 279 2000 R974 R979
16. M. Jougasaki, I. Tachibana, A. Luchner, H. Leskinen, M.M. Redfield, and J.C. Burnett Augmented cardiac cardiotrophin-1 in experimental congestive heart failure Circulation 101 2000 14 17
17. D. Elsner, and G.A. Riegger Experimental heart failure produced by rapid ventricular pacing in the dog J Card Fail 1 1995 229 247
18. C.M. Birner, C. Ulucan, S. Fredersdorf, M. Rihm, H. Löwel, and J. Stritzke Head-to-head comparison of BNP and IL-6 as markers of clinical and experimental heart failure: superiority of BNP Cytokine 40 2007 89 97
19. H. Schneider, O. Husser, M. Rihm, S. Fredersdorf, C. Birner, and S. Dhein Safety of the novel atrial-selective K+-channel blocker AVE0118 in experimental heart failure Naunyn Schmiedebergs Arch Pharmacol 379 2009 225 232
20. F.G. Spinale, D.M. Eble, R. Mukherjee, W.S. Johnson, and J.D. Walker Left ventricular and myocyte structure and function following chronic ventricular tachycardia in rabbits Basic Res Cardiol 89 1994 456 467
21. D.M. Eble, J.D. Walker, A.M. Samarel, and F.G. Spinale Myosin heavy chain synthesis during the progression of chronic tachycardia induced heart failure in rabbits Basic Res. Cardiol 93 1998 50 55
22. A. Görg, W. Weiss, and M.J. Dunn Current two-dimensional electrophoresis technology for proteomics Proteomics 4 2004 3665 3685
23. A. Görg, C. Obermaier, G. Boguth, A. Harder, B. Scheibe, and R. Wildgruber The current state of two-dimensional electrophoresis with immobilized pH gradients Electrophoresis 21 2000 1037 1053
24. Ensembl. Rabbit (Oryctolagus cuniculus). Ensembl release 60, Nov. 2010. Available from: http://www.ensembl.org/Oryctolagus-cuniculus/Info/Index.
25. Ensembl release 60, Nov 2010. Available from: ftp://ftp.ensembl.org/pub/ current/fasta/oryctolagus-cuniculus/pep/.
26. M.G. Rosca, and C.L. Hoppel Mitochondria in heart failure Cardiovasc Res 88 2010 40 50
27. A.T. Turer, C.R. Malloy, C.B. Newgard, and M.V. Podgoreanu Energetics and metabolism in the failing heart: important but poorly understood Curr Opin Clin Nutr Metab Care 13 2010 458 465
28. L. Chen, and A.A. Knowlton Mitochondria and heart failure: new insights into an energetic problem Minerva Cardioangiol 58 2010 213 229
29. Y. Burelle, M. Khairallah, A. Ascah, B.G. Allen, C.F. Deschepper, and B.J. Petrof Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart J Mol Cell Cardiol 48 2010 310 321
30. J. Marín-García, and M.J. Goldenthal Mitochondrial centrality in heart failure Heart Fail Rev 13 2008 137 150
31. A.J. Murray, L.M. Edwards, and K. Clarke Mitochondria and heart failure Curr Opin Clin Nutr Metab Care 10 2007 704 711
32. G. Agnetti, N. Kaludercic, L.A. Kane, S.T. Elliott, Y. Guo, and K. Chakir Modulation of mitochondrial proteome and improved mitochondrial function by biventricular pacing of dyssynchronous failing hearts Circ Cardiovasc Genet 3 2010 7 87
33. M. Jüllig, A.J.R. Hickey, C.C. Chai, G.L. Skea, M.J. Middleditch, and S. Costa Is the failing heart out of fuel or a worn engine running rich? A study of mitochondria in old spontaneously hypertensive rats Proteomics 8 2008 2556 2572
34. C. Cieniewski-Bernard, P. Mulder, J. Henry, H. Drobecq, E. Dubois, and G. Pottiez Proteomic analysis of left ventricular remodeling in an experimental model of heart failure J Proteome Res 7 2008 5004 5016
35. H. Bugger, M. Schwarzer, D. Chen, A. Schrepper, P.A. Amorim, and M. Schoepe Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure Cardiovasc Res 85 2010 376 384
36. E. Camors, V. Monceau, and D. Charlemagne Annexins and Ca2+ handling in the heart Cardiovasc Res 65 2005 793 802
37. A.M. Gunteski-Hamblin, G. Song, R.A. Walsh, M. Frenzke, G.P. Boivin, and G.W. Dorn Annexin VI overexpression targeted to heart alters cardiomyocyte function in transgenic mice Am J Physiol 270 1996 H1091 H1100
38. G. Song, S.E. Harding, M.R. Duchen, R. Tunwell, P. O'Gara, and T.E. Hawkins Altered mechanical properties and intracellular calcium signaling in cardiomyocytes from annexin 6 null-mutant mice FASEB J 16 2002 622 624
39. C. Nediani, L. Raimondi, E. Borchi, and E. Cerbai Nitric oxide/reactive oxygen species generation and nitroso/redox imbalance in heart failure: from molecular mechanisms to therapeutic implications Antioxid Redox Signal 14 2011 289 331
40. Z. Gao, H. Xu, D. DiSilvestre, V.L. Halperin, R. Tunin, and Y. Tian Transcriptomic profiling of the canine tachycardia-induced heart failure model: global comparison to human and murine heart failure J Mol Cell Cardiol 40 2006 76 86
41. T.M. Olson, M.L. Karst, F.G. Whitby, and D.J. Driscoll Myosin light chain mutation causes autosomal recessive cardiomyopathy with mid-cavitary hypertrophy and restrictive physiology Circulation 105 2002 2337 2340
42. K. Poetter, H. Jiang, S. Hassanzadeh, S.R. Master, A. Chang, and M.C. Dalakas Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle Nat Genet 13 1996 63 69
43. T. Dohke, A. Wada, T. Isono, M. Fujii, T. Yamamoto, and T. Tsutamoto Proteomic analysis reveals significant alternations of cardiac small heat shock protein expression in congestive heart failure J Card Fail 12 2006 77 84
44. C. Chen, B. Lee, H. Hsu, H. Lin, C. Chao, and Y. Lin A proteomic study of the effects of ramipril on post-infarction left ventricular remodelling in the rabbit Eur J Heart Fail 10 2008 740 748